Peter Sklar
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 26
- HIV/AIDS Research and Interventions 4
- Virology 17
- HIV Research and Treatment 17
- Co-authors
- Randi Y. Leavitt (14 shared papers)Anthony Rodgers (9 shared papers)Edwin DeJesus (8 shared papers)Mark J. DiNubile (7 shared papers)Jeffrey L. Lennox (5 shared papers)Michael D. Miller (7 shared papers)Adriano Lazzarin (6 shared papers)Jing Zhao (5 shared papers)
- Journals
- JAIDS Journal of Acquired Immune Deficiency Syndromes (7 papers)AIDS (5 papers)Neurology (4 papers)The Journal of Infectious Diseases (4 papers)Open Forum Infectious Diseases (4 papers)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Peter Sklar
44 papers receiving 2.2k citations
Peter Sklar's Hit Papers
Peers
Comparison fields: 5 of 79
- Virology 854
- Infectious Diseases 1.4k
- Emergency Medicine 429
- Hepatology 182
- Physiology 59
Countries citing papers authored by Peter Sklar
This map shows the geographic impact of Peter Sklar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Sklar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Sklar more than expected).
Fields of papers citing papers by Peter Sklar
This network shows the impact of papers produced by Peter Sklar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Sklar. The network helps show where Peter Sklar may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Sklar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial Hit paper breakdown → | 2009 | 483 |
| 2 | 2010 | 193 | |
| 3 | 2013 | 167 | |
| 4 | 2013 | 142 | |
| 5 | 2011 | 140 | |
| 6 | 2011 | 117 | |
| 7 | 2018 | 111 | |
| 8 | 2002 | 88 | |
| 9 | 2015 | 79 | |
| 10 | 2012 | 77 | |
| 11 | 2019 | 68 | |
| 12 | 2003 | 63 | |
| 13 | 2017 | 49 | |
| 14 | 2005 | 45 | |
| 15 | 2011 | 41 | |
| 16 | 2006 | 35 | |
| 17 | 2021 | 34 | |
| 18 | 2021 | 32 | |
| 19 | 2020 | 30 | |
| 20 | 2011 | 30 |
About Peter Sklar
Peter Sklar is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Epidemiology and Hepatology, having authored 47 papers that have together received 2.2k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (26 papers), HIV Research and Treatment (17 papers), HIV-related health complications and treatments (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), HIV/AIDS Research and Interventions (4 papers), Hepatitis C virus research (4 papers), Click Chemistry and Applications (2 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Virology (854 citations), Infectious Diseases (1.4k citations), Emergency Medicine (429 citations), Hepatology (182 citations) and Physiology (59 citations). Peter Sklar has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Randi Y. Leavitt, Anthony Rodgers, Edwin DeJesus, Mark J. DiNubile, Jeffrey L. Lennox, Michael D. Miller, Adriano Lazzarin, Jing Zhao, Bach-Yen Nguyen and Xia Xu. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, AIDS, Neurology, The Journal of Infectious Diseases and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.